Paul Barr, MD
Hematology · Rochester, NYNPI 1407946460
Payments from drug & device makers
Across 442 payments — averaging $106,983 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$41.9M
- Astrazeneca UK Limited$2.2M
- AbbVie$824K
- Eli Lilly$807K
- Pharmacyclics LLC, An Abbvie Company$559K
- Beigene, Ltd.$430K
- plus $583K from 22 others
Across 3 payments — averaging $45,399 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$136K
- AbbVie$40
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $41,901,749 |
| Astrazeneca UK Limited | 3 | $2,181,606 |
| AbbVie | 68 | $823,907 |
| Eli Lilly | 7 | $806,616 |
| Pharmacyclics LLC, An Abbvie Company | 163 | $559,200 |
| Beigene, Ltd. | 28 | $430,284 |
| Merck | 7 | $204,411 |
| TG Therapeutics, Inc. | 9 | $96,927 |
| Incyte Corporation | 30 | $83,882 |
| Beone Medicines USA, Inc. | 7 | $57,233 |
| Beone Medicines Ltd. | 14 | $29,007 |
| Janssen Research & Development, LLC | 1 | $28,562 |
| E.r. Squibb & Sons, L.L.C. | 5 | $24,020 |
| Beigene USA, Inc. | 12 | $16,413 |
| Johnson & Johnson | 8 | $7,394 |
| Acerta Pharma LLC | 3 | $6,476 |
| Bristol Myers Squibb | 4 | $5,787 |
| Genentech, Inc. | 7 | $4,353 |
| Janssen Global Services, LLC | 5 | $3,637 |
| Janssen Scientific Affairs, LLC | 1 | $2,778 |
| Adaptive Biotechnologies Corporation | 3 | $2,734 |
| Seagen Inc. | 1 | $2,063 |
| ADC Therapeutics America, Inc. | 1 | $1,750 |
| Genentech USA, Inc. | 8 | $1,626 |
| Sekisui Diagnostics LLC | 4 | $1,330 |
| GSK | 1 | $1,300 |
| Bayer | 1 | $1,260 |
| Acrotech Biopharma Inc. | 1 | $12 |
How this compares
$47,286,313 in reported general payments places this provider in the 95th percentile of 157 hematology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Rochester
- Carla CasuloRochester$2.9M
- Kristen O DwyerRochester$1.9M
- Jane LiesveldRochester$1.5M
- Ajay DhakalRochester$658K
- Andrew EvansRochester$615K
- Jainulabdeen IfthikharuddinRochester$429K
- Deborah MulfordRochester$402K
- Jason MendlerRochester$294K
- Jonathan FriedbergRochester$231K
- Alissa HustonRochester$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.